Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
775.95
Change Change %
-0.20 -0.03%

Updated:19 Sep, 2018, 15:57 PM IST

BSE
775.70
Change Change %
-0.90 -0.12%

Updated:19 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
29-11-2013 Buy 295.00 425.00
N/A
Target Hit Long (1Y)
29-11-2014

Bank of America Merrill Lynch initiates Aurobindo Pharma with buy

Potential of a turnaround with re-rating. US to drive 34 per cent revenue during FY13-16E CAGR. Profitability improving as balance sheet strengthens. Target Rs 425.

Top